US Drug Recall Register
Class II · Moderate risk Terminated Initiated May 7, 2018 (8 years ago)

SDA Senna Syrup

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.

What was recalled

SDA Senna Syrup (Sennosides 8.8mg), packaged in 8 FL. OZ. (236 mL) bottles, Distributed by SDA Laboratories 280 Railroad Avenue, Greenwich CT 06830, NDC 66424-562-08, UPC 366424562082

Recalling firm
RIJ Pharmaceutical LLC
NDC code
66424-562-08
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0851-2018

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Sennosides recalls

See all
Class I · High risk Terminated

SENNA Syrup

Reason Microbial Contamination of Non-Sterile Product

Lohxa, LLC NDC 50262-731-24 D-0377-2022
Class III · Low risk Terminated

Sankaijo BOTANICAL LAXATIVE

Reason Subpotent Drug: Formulated amount of sennosides component is less than labelled claim.

Sato Pharmaceutical Inc. NDC 49873-404-01 D-0303-2020
Class II · Moderate risk Terminated

Senna

Reason Failed Impurities/Degradation Specifications: Atypical odor and unpleasant taste was reported

Geritrex, LLC NDC 54162-007-08 D-1437-2019
Class II · Moderate risk Terminated

Senna

Reason Failed Impurities/Degradation Specifications: Atypical odor and unpleasant taste was reported

Geritrex, LLC NDC 53807-556-08 D-1436-2019
Class II · Moderate risk Terminated

Geritrex Senna Syrup

Reason CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.

RIJ Pharmaceutical LLC NDC 54162-007-08 D-0850-2018